1. Induction of muscle weakness by local inflammation: an experimental animal model

   • S. Bicer
   • P. J. Reiser
   • N. Quan

   OriginalPaper 11 February 2009 Pages: 175 - 183

2. Inhibitory effect of ZPDC glycoprotein on the expression of inflammation-related cytokines through p38 MAP kinase and JNK in lipopolysaccharide-stimulated RAW 264.7 cells

   • S.-J. Lee
   • K.-T. Lim

   OriginalPaper 13 February 2009 Pages: 184 - 191

3. Concentrations of α- and β-defensins in plasma of patients with inflammatory bowel disease

   • N. Yamaguchi
   • H. Isomoto
   • S. Kohno

   OriginalPaper 31 January 2009 Pages: 192 - 197

4. Neutrophil elastase inhibitor (sivelestat) reduces the Levels of inflammatory mediators by inhibiting NF-kB

   • S. Hagiwara
   • H. Iwasaka
   • T. Noguchi

   OriginalPaper 24 February 2009 Pages: 198 - 203

5. A new model of outbred genetically selected mice which present a strong acute inflammatory response in the absence of complement component C5

   • M. T. Amano
   • A. S. Carneiro
   • N. Starobinas

   OriginalPaper 24 January 2009 Pages: 204 - 209

6. Suramin inhibits macrophage activation by human group IIA phospholipase A₂, but does not affect bactericidal activity of the enzyme

   • E. A. Aragão
   • L. Chioato
   • R. J. Ward

   OriginalPaper 24 January 2009 Pages: 210 - 217

7. 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn’s disease in Tunisian population

   • R. Marrakchi
   • K. Bougatef
   • A. Benammar-Elgaaeid

   OriginalPaper 30 January 2009 Pages: 218 - 223

8. Enhancement of activated β₁-integrin expression by prostaglandin E₂ via EP receptors in isolated human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease

   • M. Kajimoto
   • T. Ichiyama
   • S. Furukawa

   OriginalPaper 24 January 2009 Pages: 224 - 228